UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
17 min read

Smarter than AI: A Commentary on Serendipitous Drug Discovery

One in four drugs traces its origin to serendipity—unexpected discoveries that changed medicine forever. From penicillin to GLP-1s now projected to reach $100 billion by 2030, the most transformative treatments often emerge when researchers pay attention to "off-target" effects. As AI reshapes drug development, human observation and patient-centered design remain our most powerful tools for breakthrough discoveries.
Judy Lytle
Executive Director, Evidence Development Study Solutions

Posts by Date

Close up of man holding cellphone with a chat bubble popping out of the screen.
Blog
8 min read

Key Technology Considerations for Patient Services

Director, Software Development & Engineering Michael Calahan discusses the key technology considerations for patient services providers.
Elderly female patient holds her phone and uses the QR camera to scan a document's QR code.
Blog
3 min read

Patient Services: Technology Forward, But Patients First

What does it look like to prioritize individual patient needs while blending the best technology into patient services?
Business team of 5 diverse individuals reviewing and making notes on several reports scattered across the boardroom table.
Blog
4 min read

When to Start Thinking About Risk Management and How to Prepare for a REMS

Learn about the importance of preparation and contingency planning for risk management and REMS.
Man touching screen with his finger and AI robot touching the screen from the other side of the device.
Articles
2 min read

Evaluating Existing Safety Surveillance Regulations for Drug Development

UBC's pharmacovigilance experts compare current safety regulations in Advances in Therapy.
Executive male and female analyze data on a scatter chart and other surrounding graphs.
Articles
25 min read

External Controls in Research: The “What, Why and How”

Experts across various domains come together to discuss and highlight various key aspects of using external control arms.
Female data scientist analyzes and plots data points on a candlestick chart
Blog
6 min read

Maximize Gross-to-Net While Optimizing Your Patient Service Strategy

Patient service programs can often overextend themselves relative to a brand's revenue. Read how to avoid this in three key areas.
Close up of hand being compassionately embraced by a fellow woman.
Blog
4 min read

Driving Patient Services that Place the Patient at the Center

Are you taking the time to put patients at the center of your support services? And what does that look like?
Young female data scientist writes notes and wireframe on a whiteboard as she diagrams out a process.
Blog
8 min read

Moving Safety Activities Forward – Fierce Pharma Drug Safety Summit 2023

Learn about the key themes in REMS and pharmacovigilance that were discussed at this industry conference.
Confident woman reviews several screens of analytics and data points and makes a selection by touching one of the screens
Blog
5 min read

Regulatory Update: Selective Safety Data Collection in Clinical Research

Read how the latest guidance from the FDA could change what safety data you need to collect.
1 7 8 9 10 11 18

Press Inquires

UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.